Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential

Abstract Immunotherapy, including immunostimulation and immunosuppression, has seen significant development in the last 10 years. Immunostimulation has been verified as effective in anti-cancer treatment, while immunosuppression is used in the treatment of autoimmune disease and inflammation. Curren...

Full description

Bibliographic Details
Main Authors: Jing Wen, Dale Creaven, Xiangshu Luan, Jiemin Wang
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-023-04342-w
_version_ 1797773943931666432
author Jing Wen
Dale Creaven
Xiangshu Luan
Jiemin Wang
author_facet Jing Wen
Dale Creaven
Xiangshu Luan
Jiemin Wang
author_sort Jing Wen
collection DOAJ
description Abstract Immunotherapy, including immunostimulation and immunosuppression, has seen significant development in the last 10 years. Immunostimulation has been verified as effective in anti-cancer treatment, while immunosuppression is used in the treatment of autoimmune disease and inflammation. Currently, with the update of newly-invented simplified isolation methods and the findings of potent triggered immune responses, extracellular vesicle-based immunotherapy is very eye-catching. However, the research on three main types of extracellular vesicles, exosomes, microvesicles and apoptotic bodies, needs to be more balanced. These three subtypes share a certain level of similarity, and at the same time, they have their own properties caused by the different methods of biogensis. Herein, we summarized respectively the status of immunotherapy based on each kind of vesicle and discuss the possible involved mechanisms. In conclusion, we highlighted that the effect of the apoptotic body is clear and strong. Apoptotic bodies have an excellent potential in immunosuppressive and anti-inflammatory therapies .
first_indexed 2024-03-12T22:13:38Z
format Article
id doaj.art-3642b9deaf8340929e03f6b78275593c
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-03-12T22:13:38Z
publishDate 2023-07-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-3642b9deaf8340929e03f6b78275593c2023-07-23T11:25:32ZengBMCJournal of Translational Medicine1479-58762023-07-0121111410.1186/s12967-023-04342-wComparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potentialJing Wen0Dale Creaven1Xiangshu Luan2Jiemin Wang3Department of Pharmacy, The Third Hospital of ChangshaRegenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, University of GalwaySchool of Life Science and Technology, China Pharmaceutical UniversityRegenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, University of GalwayAbstract Immunotherapy, including immunostimulation and immunosuppression, has seen significant development in the last 10 years. Immunostimulation has been verified as effective in anti-cancer treatment, while immunosuppression is used in the treatment of autoimmune disease and inflammation. Currently, with the update of newly-invented simplified isolation methods and the findings of potent triggered immune responses, extracellular vesicle-based immunotherapy is very eye-catching. However, the research on three main types of extracellular vesicles, exosomes, microvesicles and apoptotic bodies, needs to be more balanced. These three subtypes share a certain level of similarity, and at the same time, they have their own properties caused by the different methods of biogensis. Herein, we summarized respectively the status of immunotherapy based on each kind of vesicle and discuss the possible involved mechanisms. In conclusion, we highlighted that the effect of the apoptotic body is clear and strong. Apoptotic bodies have an excellent potential in immunosuppressive and anti-inflammatory therapies .https://doi.org/10.1186/s12967-023-04342-wImmunotherapyImmunostimulatoryImmunomodulatoryExtracellular vesiclesApoptotic bodiesMicrovesicles
spellingShingle Jing Wen
Dale Creaven
Xiangshu Luan
Jiemin Wang
Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
Journal of Translational Medicine
Immunotherapy
Immunostimulatory
Immunomodulatory
Extracellular vesicles
Apoptotic bodies
Microvesicles
title Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_full Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_fullStr Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_full_unstemmed Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_short Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
title_sort comparison of immunotherapy mediated by apoptotic bodies microvesicles and exosomes apoptotic bodies unique anti inflammatory potential
topic Immunotherapy
Immunostimulatory
Immunomodulatory
Extracellular vesicles
Apoptotic bodies
Microvesicles
url https://doi.org/10.1186/s12967-023-04342-w
work_keys_str_mv AT jingwen comparisonofimmunotherapymediatedbyapoptoticbodiesmicrovesiclesandexosomesapoptoticbodiesuniqueantiinflammatorypotential
AT dalecreaven comparisonofimmunotherapymediatedbyapoptoticbodiesmicrovesiclesandexosomesapoptoticbodiesuniqueantiinflammatorypotential
AT xiangshuluan comparisonofimmunotherapymediatedbyapoptoticbodiesmicrovesiclesandexosomesapoptoticbodiesuniqueantiinflammatorypotential
AT jieminwang comparisonofimmunotherapymediatedbyapoptoticbodiesmicrovesiclesandexosomesapoptoticbodiesuniqueantiinflammatorypotential